SPRUCE BIOSCIENCES, INC.

For the period ended Jun 30, 2026. Filed Aug 12, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 12, 2026

SPRB$46.55+9.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Balance Sheets

(in thousands, except share and per share amounts)

	June 30,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$96,295	$48,906
Prepaid expenses	4,625	353
Other current assets	234	2,853
Total current assets	101,154	52,112
Right-of-use assets	523	666
Other assets	1,175	243
Total assets	$102,852	$53,021
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,209	$943
Accrued expenses and other current liabilities	7,254	9,143
Debt, current portion	2,500	—
Total current liabilities	10,963	10,086
Lease liabilities, net of current portion	245	419
Debt, net of current portion	4,591	—
Warrant liability	3,323	—
Total liabilities	19,122	10,505
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of June 30, 2026 and December 31, 2025	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 2,752,810 and 1,372,043 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	401,459	331,750
Accumulated deficit	(317,729)	(289,234)
Total stockholders’ equity	83,730	42,516
Total liabilities and stockholders’ equity	$102,852	$53,021

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.